XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Revision of Prior Period, Adjustment [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Beginning balance at Dec. 31, 2020 $ 1,169 $ 1,169 $ 7 $ 1 $ 6 $ 66,667 $ 66,673 $ (6) $ (65,505) $ (65,505)
Beginning balance (in shares) at Dec. 31, 2020     65,742,883 45,156,145 20,586,738          
Capital contribution from Amprius Holdings 20,111         20,111        
Exercise of stock options (in shares)     29,118              
Exercise of stock options 1         1        
Stock-based compensation 1,000         1,000        
Contribution from Amprius Holdings related to stock-based compensation 1,473         1,473        
Net income (loss) (9,896)         0     (9,896)  
Ending balance at Dec. 31, 2021 13,858   $ 7     89,252     (75,401)  
Ending balance (in shares) at Dec. 31, 2021     65,772,001              
Capital contribution from Amprius Holdings 505         505        
Exercise of stock options (in shares)     146,566              
Exercise of stock options 44         44        
Issuance of common stock in connection with business combination and PIPE investment, net of issuance costs, shares     18,392,366              
Issuance of common stock in connection with business combination and PIPE investment, net of issuance costs 70,938   $ 1     70,937        
Issuance of common stock in connection with a stock purchase agreement, shares     84,793              
Stock-based compensation 2,329         2,329        
Cumulative effect adjustment from adoption of ASC 842 (154)               (154)  
Exercise of stock warrants (in shares)     214,388              
Exercise of stock warrants 2,465         2,465        
Contribution from Amprius Holdings related to stock-based compensation 380         380        
Net income (loss) (17,332)               (17,332)  
Ending balance at Dec. 31, 2022 $ 73,033   $ 8     $ 165,912     $ (92,887)  
Ending balance (in shares) at Dec. 31, 2022     84,610,114